---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-020698"
form_type: "8-K"
ticker: "FHTX"
cik: "0001822462"
company_name: "Foghorn Therapeutics Inc."
filed_at: "2024-05-06T23:59:59+00:00"
generated_at: "2026-06-02T22:20:24.188210+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Foghorn posts investor presentation; no material financial or pipeline updates disclosed

## Summary
- Company posted a corporate presentation to its website on May 6, 2024, for use in investor meetings.
- Presentation attached as Exhibit 99.1 contains cover slide only; no specific financial data, clinical milestones, or guidance provided.
- No changes to previously disclosed business strategy or pipeline status were announced.
- Filing contains no earnings results, regulatory actions, or material contracts.

## SEC filing metadata
- accession: 0001628280-24-020698
- form_type: 8-K
- ticker: FHTX
- cik: 0001822462
- company_name: Foghorn Therapeutics Inc.
- filed_at: 2024-05-06T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1822462/000162828024020698/0001628280-24-020698-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1822462/000162828024020698/fhtx-20240506.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-020698
- JSON: https://secwatch.observer/filing/0001628280-24-020698.json
- Plain text: https://secwatch.observer/filing/0001628280-24-020698.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.